Biochemical Characterization and Molecular Determination of Estrogen Receptor-α (ESR1 PvuII-rs2234693 T>C) and MiRNA-146a (rs2910164 C>G) Polymorphic Gene Variations and Their Association with the Risk of Polycystic Ovary Syndrome

• Published in: International journal of environmental research and public health Vol. 19; no. 5; p. 3114
• Main Authors: Mir, Rashid, Tayeb, Faris J., Barnawi, Jameel, Jalal, Mohammed M., Saeedi, Nizar H., Hamadi, Abdullah, Altayar, Malik A., Alshammari, Sanad E., Mtiraoui, Nabil, Ali, Mohammed Eltigani, Duhier, Faisel M. Abu, Ullah, Mohammad Fahad
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 06.03.2022; MDPI
• Subjects: Case-Control Studies; Diabetes; Disease; Epigenetics; Estrogen Receptor alpha - genetics; Estrogens; Female; Gene expression; Gene Frequency; Genetic Predisposition to Disease; Humans; Insulin resistance; Kinases; Lipids; Metabolism; MicroRNAs; MicroRNAs - genetics; Ovaries; Pathogenesis; Polycystic ovary syndrome; Polycystic Ovary Syndrome - genetics; Polycystic Ovary Syndrome - metabolism; Polymorphism; Polymorphism, Single Nucleotide; Receptors, Estrogen; Womens health; Germany; polymorphism; gene variations; endocrine; polycystic ovary syndrome
• DOI: 10.3390/ijerph19053114
• ISSN: 1660-4601; 1661-7827

Polycystic ovary syndrome (PCOS) is regarded as one of the most frequently encountered endocrine disorders and affects millions of young women worldwide, resulting in an array of complex metabolic alterations and reproductive failure. PCOS is a risk factor for diabetes mellitus, obstructive sleep apnea, obesity and depression in patients. Estrogen receptors (ESRs) are significant candidates in endocrine function and ovarian response in women. Moreover, microRNAs and long non-coding RNAs are emerging as principal mediators of gene expression and epigenetic pathways in various disease states. This study has characterized the clinical parameters in PCOS patients with comprehensive biochemical profiling compared to healthy controls and further examined the influence of allelic variations for estrogen receptor-α (ESR1 PvuII-rs2234693 T>C) and miRNA-146a (rs2910164 C>G) gene polymorphism on the risk of and susceptibility to PCOS. In this case-control study, we have used amplification refractory mutation specific (ARMS)-PCR to detect and determine the presence of these polymorphic variants in the study subjects. Our results demonstrated that most of the biochemical markers, which were analyzed in the study, show statistically significant alterations in PCOS patients, including fasting glucose, free insulin, HOMA-IR, LDL, HDL, cholesterol and hormones such as FSH, LH, testosterone and progesterone, which correlate with the established biochemical alterations in the disorder. Further, it is reported that for estrogen receptor-α (ESR1 PvuII-rs2234693 T>C), the frequency of the T allele (fT) was significantly higher among patients (0.64 vs. 0.44) compared to controls, while the frequency of the C allele (fC) was lower in patients (0.36 vs. 0.56) compared to controls. However, it was found that there was no association of an increased risk of PCOS with the ESR1 PvuII-rs2234693 C>T gene polymorphism. On the contrary, the study found strong association of miRNA-146a (rs2910164 C>G) gene polymorphism with an enhanced risk of PCOS. The frequency of the C allele (fC) was significantly higher among patients (0.52 vs. 0.36) compared to controls. The frequency of the G allele (fG) was found to be lower in patients (0.48 vs. 0.64) compared to controls. The codominant, dominant and recessive models display a statistically significant association of polymorphic variations with PCOS. Moreover, the G allele was associated strongly with PCOS susceptibility with an OR = 1.92 (95%) CI = (1.300–2.859), RR = 1.38 (1.130–1.691) p-value < 0.001.